Good earnings but it does not justify the share price appreciation. I am not giving overweight calls for Kotra Industries. Someone else will probably inverse my opinion and buy tomorrow. But I will be seller of Kotra for the short term. Long term investment remains optimistic
Kotra's is merely traded at PER 12.5x whereas Ahealth, Dpharma, Yspsah and Nova are all fetched PER between 17x and 22x. Time to catch up with the valuation
Monopoly over the local pharmaceutical business. There is not a single company listed on Bursa that has their in-house manufacturing line and brands. Give me one company except Pharmaniaga that actually deals with production. None
Thanks zzprozaz. Surged in profit margin is highly likely due to increasing in appeton products sales. Nova is another one enjoying high profit margin from its supplement products.
IR's job is to make presentation decks and help analysts prepare models. Their information can be found anywhere. Surge in profit margins has been priced in. The time to buy was Q3 2021
Kotra has invested RM 179m in PPE from FY2010 to FY2021 and the accumulated depreciation is about RM 124m during this period. With the PPE depreciation in RM 14m per annum and nil massive Capex, the depreciation amount will be reduced RM 3m/year after 3 years.
Kotra needs to prove to the market that its margin hike is sustainable for 4 continuous quarters . Therefore, the upcoming QR is crucial justify the margin leap.
Appeton sales in Jan to March should be good as higher covid cases in this period, recent 2 quarters result mainly support by higher local sales mainly contribute by Appeton in the covid period
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
wallstreetrookie
9,784 posts
Posted by wallstreetrookie > 2022-02-10 15:25 | Report Abuse
Kotra Industries to report earnings next week. Check your Bloomberg terminal for implied move and previous EPS estimates. Good luck